Oliver Keppler (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Oliver Keppler" in German language version.

refsWebsite
Global rank German rank
2nd place
3rd place
4th place
7th place
low place
low place
3,337th place
464th place
low place
low place
low place
low place
5,704th place
362nd place
1st place
1st place
33rd place
2nd place

doi.org (Global: 2nd place; German: 3rd place)

  • Oliver T. Keppler, Frank J. Welte, Tuan A. Ngo, Peggy S. Chin, Kathryn S. Patton: Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1. In: Journal of Experimental Medicine. Band 195, Nr. 6, 18. März 2002, S. 719–736, doi:10.1084/jem.20011549, PMID 11901198, PMC 2193739 (freier Volltext).
  • Christine Goffinet, Ina Allespach, Stefanie Homann, Hanna-Mari Tervo, Anja Habermann: HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor. In: Cell Host & Microbe. Band 5, Nr. 3, 19. März 2009, S. 285–297, doi:10.1016/j.chom.2009.01.009, PMID 19286137.
  • Christine Goffinet, Ina Allespach, Oliver T. Keppler: HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. In: Proceedings of the National Academy of Sciences. Band 104, Nr. 3, 16. Januar 2007, S. 1015–1020, doi:10.1073/pnas.0607414104, PMID 17209012, PMC 1783356 (freier Volltext).
  • Hanna-Mari Baldauf, Xiaoyu Pan, Elina Erikson, Sarah Schmidt, Waaqo Daddacha: SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. In: Nature Medicine. Band 18, Nr. 11, November 2012, S. 1682–1688, doi:10.1038/nm.2964, PMID 22972397, PMC 3828732 (freier Volltext).
  • Hanna-Mari Baldauf, Lena Stegmann, Sarah-Marie Schwarz, Ina Ambiel, Maud Trotard: Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells. In: Proceedings of the National Academy of Sciences. Band 114, Nr. 10, 22. Februar 2017, S. 2729–2734, doi:10.1073/pnas.1613635114, PMID 28228523, PMC 5347584 (freier Volltext).
  • Constanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, Sarah-Marie Schwarz, Dominique Thomas: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. In: Nature Medicine. Band 23, Nr. 2, Februar 2017, S. 250–255, doi:10.1038/nm.4255.
  • Thomas Oellerich, Constanze Schneider, Dominique Thomas, Kirsten M. Knecht, Olga Buzovetsky: Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. In: Nature Communications. Band 10, Nr. 1, Dezember 2019, S. 3475, doi:10.1038/s41467-019-11413-4, PMID 31375673, PMC 6677770 (freier Volltext).
  • Maximilian Muenchhoff, Helga Mairhofer, Hans Nitschko, Natascha Grzimek-Koschewa, Dieter Hoffmann: Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. In: Eurosurveillance. Band 25, Nr. 24, 18. Juni 2020, S. 2001057, doi:10.2807/1560-7917.ES.2020.25.24.2001057, PMID 32583765, PMC 7315722 (freier Volltext).
  • Andreas Osterman, Hanna-Mari Baldauf, Marwa Eletreby, Jochen M. Wettengel, Suliman Q. Afridi: Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. In: Medical Microbiology and Immunology. Band 210, Nr. 1, Februar 2021, S. 65–72, doi:10.1007/s00430-020-00698-8, PMID 33452927, PMC 7811156 (freier Volltext).
  • Maximilian Muenchhoff, Alexander Graf, Stefan Krebs, Caroline Quartucci, Sandra Hasmann: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. In: Eurosurveillance. Band 26, Nr. 43, 28. Oktober 2021, doi:10.2807/1560-7917.ES.2021.26.43.2002066, PMID 34713795, PMC 8555370 (freier Volltext).
  • Christopher Dächert, Maximilian Muenchhoff, Alexander Graf, Hanna Autenrieth, Sabine Bender: Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. In: Medical Microbiology and Immunology. Band 211, Nr. 1, Februar 2022, S. 71–77, doi:10.1007/s00430-022-00728-7, PMID 35061086, PMC 8780046 (freier Volltext).
  • Andreas Osterman, Irina Badell, Elif Basara, Marcel Stern, Fabian Kriesel: Impaired detection of omicron by SARS-CoV-2 rapid antigen tests. In: Medical Microbiology and Immunology. 20. Februar 2022, doi:10.1007/s00430-022-00730-z, PMID 35187580, PMC 8858605 (freier Volltext).
  • Paul R. Wratil, Niklas A. Schmacke, Andreas Osterman, Tobias Weinberger, Jochen Rech: In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers. In: Infection. Band 50, Nr. 2, 11. August 2021, S. 381–394, doi:10.1007/s15010-021-01672-z, PMID 34379308, PMC 8354838 (freier Volltext).
  • Paul R. Wratil, Niklas A. Schmacke, Burak Karakoc, Alex Dulovic, Daniel Junker: Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses. In: Cell Reports. Band 37, Nr. 13, Dezember 2021, S. 110169, doi:10.1016/j.celrep.2021.110169, PMID 34932974, PMC 8648802 (freier Volltext).
  • Paul R. Wratil, Marcel Stern, Alina Priller, Annika Willmann, Giovanni Almanzar: Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. In: Nature Medicine. Band 28, Nr. 3, März 2022, S. 496–503, doi:10.1038/s41591-022-01715-4.
  • Hristo L. Svilenov, Julia Sacherl, Alwin Reiter, Lisa S. Wolff, Cho-Chin Cheng: Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein. In: Antiviral Research. Band 196, Dezember 2021, S. 105197, doi:10.1016/j.antiviral.2021.105197, PMID 34774603, PMC 8579703 (freier Volltext).
  • Paul R. Wratil, Marcel Stern, Alina Priller, Annika Willmann, Giovanni Almanzar: Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern. In: Nature Medicine. Band 28, Nr. 3, März 2022, S. 496–503, doi:10.1038/s41591-022-01715-4.

g-f-v.org (Global: low place; German: low place)

hhmi.org (Global: low place; German: low place)

idw-online.de (Global: 5,704th place; German: 362nd place)

nih.gov (Global: 4th place; German: 7th place)

ncbi.nlm.nih.gov

  • Oliver T. Keppler, Frank J. Welte, Tuan A. Ngo, Peggy S. Chin, Kathryn S. Patton: Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1. In: Journal of Experimental Medicine. Band 195, Nr. 6, 18. März 2002, S. 719–736, doi:10.1084/jem.20011549, PMID 11901198, PMC 2193739 (freier Volltext).
  • Christine Goffinet, Ina Allespach, Stefanie Homann, Hanna-Mari Tervo, Anja Habermann: HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor. In: Cell Host & Microbe. Band 5, Nr. 3, 19. März 2009, S. 285–297, doi:10.1016/j.chom.2009.01.009, PMID 19286137.
  • Christine Goffinet, Ina Allespach, Oliver T. Keppler: HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. In: Proceedings of the National Academy of Sciences. Band 104, Nr. 3, 16. Januar 2007, S. 1015–1020, doi:10.1073/pnas.0607414104, PMID 17209012, PMC 1783356 (freier Volltext).
  • Hanna-Mari Baldauf, Xiaoyu Pan, Elina Erikson, Sarah Schmidt, Waaqo Daddacha: SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. In: Nature Medicine. Band 18, Nr. 11, November 2012, S. 1682–1688, doi:10.1038/nm.2964, PMID 22972397, PMC 3828732 (freier Volltext).
  • Hanna-Mari Baldauf, Lena Stegmann, Sarah-Marie Schwarz, Ina Ambiel, Maud Trotard: Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells. In: Proceedings of the National Academy of Sciences. Band 114, Nr. 10, 22. Februar 2017, S. 2729–2734, doi:10.1073/pnas.1613635114, PMID 28228523, PMC 5347584 (freier Volltext).
  • Thomas Oellerich, Constanze Schneider, Dominique Thomas, Kirsten M. Knecht, Olga Buzovetsky: Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. In: Nature Communications. Band 10, Nr. 1, Dezember 2019, S. 3475, doi:10.1038/s41467-019-11413-4, PMID 31375673, PMC 6677770 (freier Volltext).
  • Maximilian Muenchhoff, Helga Mairhofer, Hans Nitschko, Natascha Grzimek-Koschewa, Dieter Hoffmann: Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. In: Eurosurveillance. Band 25, Nr. 24, 18. Juni 2020, S. 2001057, doi:10.2807/1560-7917.ES.2020.25.24.2001057, PMID 32583765, PMC 7315722 (freier Volltext).
  • Andreas Osterman, Hanna-Mari Baldauf, Marwa Eletreby, Jochen M. Wettengel, Suliman Q. Afridi: Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. In: Medical Microbiology and Immunology. Band 210, Nr. 1, Februar 2021, S. 65–72, doi:10.1007/s00430-020-00698-8, PMID 33452927, PMC 7811156 (freier Volltext).
  • Maximilian Muenchhoff, Alexander Graf, Stefan Krebs, Caroline Quartucci, Sandra Hasmann: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. In: Eurosurveillance. Band 26, Nr. 43, 28. Oktober 2021, doi:10.2807/1560-7917.ES.2021.26.43.2002066, PMID 34713795, PMC 8555370 (freier Volltext).
  • Christopher Dächert, Maximilian Muenchhoff, Alexander Graf, Hanna Autenrieth, Sabine Bender: Rapid and sensitive identification of omicron by variant-specific PCR and nanopore sequencing: paradigm for diagnostics of emerging SARS-CoV-2 variants. In: Medical Microbiology and Immunology. Band 211, Nr. 1, Februar 2022, S. 71–77, doi:10.1007/s00430-022-00728-7, PMID 35061086, PMC 8780046 (freier Volltext).
  • Andreas Osterman, Irina Badell, Elif Basara, Marcel Stern, Fabian Kriesel: Impaired detection of omicron by SARS-CoV-2 rapid antigen tests. In: Medical Microbiology and Immunology. 20. Februar 2022, doi:10.1007/s00430-022-00730-z, PMID 35187580, PMC 8858605 (freier Volltext).
  • Paul R. Wratil, Niklas A. Schmacke, Andreas Osterman, Tobias Weinberger, Jochen Rech: In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers. In: Infection. Band 50, Nr. 2, 11. August 2021, S. 381–394, doi:10.1007/s15010-021-01672-z, PMID 34379308, PMC 8354838 (freier Volltext).
  • Paul R. Wratil, Niklas A. Schmacke, Burak Karakoc, Alex Dulovic, Daniel Junker: Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses. In: Cell Reports. Band 37, Nr. 13, Dezember 2021, S. 110169, doi:10.1016/j.celrep.2021.110169, PMID 34932974, PMC 8648802 (freier Volltext).
  • Hristo L. Svilenov, Julia Sacherl, Alwin Reiter, Lisa S. Wolff, Cho-Chin Cheng: Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein. In: Antiviral Research. Band 196, Dezember 2021, S. 105197, doi:10.1016/j.antiviral.2021.105197, PMID 34774603, PMC 8579703 (freier Volltext).

p-e-g.org (Global: low place; German: low place)

  • Wolfgang Stille-Preis. Paul-Ehrlich-Gesellschft für Infektionstherapie e. V., abgerufen am 26. März 2022.

redirecter.toolforge.org (Global: 33rd place; German: 2nd place)

  • Verleihung des Rolf Becker-Preises 2022 auf dem Jahresempfang der Medizinischen Fakultät. Ludwig-Maximilians-Universität München, 16. Juli 2022, archiviert vom Original am 17. August 2022; abgerufen am 4. August 2022.

uni-muenchen.de (Global: 3,337th place; German: 464th place)

mvp.uni-muenchen.de

web.archive.org (Global: 1st place; German: 1st place)

  • Verleihung des Rolf Becker-Preises 2022 auf dem Jahresempfang der Medizinischen Fakultät. Ludwig-Maximilians-Universität München, 16. Juli 2022, archiviert vom Original am 17. August 2022; abgerufen am 4. August 2022.